Safety and efficacy of 3% diquafosol ophthalmic solution for soft contact lens-related dry eye.
Phase of Trial: Phase II
Latest Information Update: 20 Mar 2018
At a glance
- Drugs Diquafosol (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Santen Pharmaceutical
- 19 Mar 2018 Status changed from active, no longer recruiting to completed.
- 22 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Sep 2016 New trial record